Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSIF.L Regulatory News (SSIF)

  • There is currently no data for SSIF

Portfolio Update

2 Aug 2017 10:45

RNS Number : 8807M
SQN Secured Income Fund PLC
02 August 2017
Β 

For immediate release 2 August 2017

Β 

Β 

Β 

SQN Secured Income Fund plc

Portfolio Update - positive momentum - Fund now fully committed

Β 

SQN Secured Income Fund plc (LSE: SSIF) (the "Company" or "SSIF"), a UK-listed specialist investment trust with a focus on secured investments that produce regular income, is pleased to update shareholders of SSIF on the progress made since SQN Capital Management, LLC together with its UK subsidiary SQN Asset Management Limited (together "SQN") were appointed as the Company's investment managers on 1 April 2017.

Β 

Highlights

Β 

Β· Appointment by SQN of Dawn Kendall as managing director with effect from 1 August 2017 and other key hires in pipeline

Β· Strategic review and resulting rationalisation of platform-originated or related investments completed

Β· Full commitment of available cash primarily into SQN-originated transactions

Β· Gross yield on portfolio expected to rise approximately to 8.6%1

Β· On track to pay targeted dividend of 6.25p per share for current financial year2

Β 

Β 

Strategic Review

Β 

Following its appointment in April 2017, SQN has completed a thorough strategic review of the Company's platform investments.

Β 

At the time of SQN's appointment, approximately 31% of the Company's assets were in cash with the remainder already invested via platforms and through working capital loans to platforms. Following the review, a decision has been taken to cease making working capital loans to platforms and to reduce the number of platforms through which the Company conducts business. The selection of preferred platforms has been made after an in-depth analysis of their credit processes and sector preferences, with a focus on diversification, "best in class" and transparency. The Company is confident that relationships with these remaining platforms are strong and will continue to provide consistent attractive deal flow. In the future, the Company expects the percentage of the Company's portfolio represented by platform-originated loans to reduce in favour of direct lending using SQN's own origination capabilities. However, as the Company grows, the amount of funds that the Company will continue to allocate to platforms will remain meaningful.

Β 

Almost a third of the Company's assets have now been invested or committed under the SQN mandate with the available cash primarily deployed into direct lending opportunities originated by SQN. The nature of these direct loans is diverse and provides high levels of security with regard to covenant provision. Each loan has been established making use of SQN's extensive network of industry contacts and all loans have been extended at rates of interest commensurate with exceeding the Company's target returns (a target annual dividend of 6.25p per share for the current financial year, increasing to at least 7.0p per share with effect from July 2018, and a target annual total return of at least 8%2).

Β 

Examples of the loans extended include:

Β 

Β· A loan to a specialist medical equipment provider which delivers unique laser therapy in the field of tumour treatment. Unusually, this company has been awarded a long, seven-year contract with the NHS.

Β 

Β· SQN has been active in film finance for some time and the team has built a strong relationship with a valued production company in this sector. Working with SQN's partners, SSIF has been able to structure loans against pre-release sales receivables from major studios and distributers, thereby providing a high level of security.

Β 

Β· Loans to two businesses in the finance sector, a leasing business offering facilities to retail operations across the country and a market leading company offering working capital loans to a broad spectrum of UK-based businesses. Both companies have a strong reputation, operate away from the web-based "peer to peer" lending sector and have had below-average defaults over the history of their loan origination.

Β 

The Company has additionally made further commitments to a listed specialised LED manufacturer based in the UK and Ireland.

Β 

All loans have been negotiated at good commercial rates, meeting the Company's requirements after fees and expenses for its target returns to shareholders2. Most pleasing is that the loans are with businesses with whom the Company expects to nurture long term relationships as they grow.

Β 

SQN's Investment in Infrastructure

Β 

As previously announced, to strengthen its team, SQN has appointed Dawn Kendall as managing director. In addition, SQN has made further experienced hires for its credit, portfolio reporting and legal teams. SQN intends to recruit further personnel in administration roles in the final quarter of 2017. This commitment is in preparation for future growth of the Company and SQN's direct lending business generally and is indicative of the importance of this division to the SQN group.

Β 

SQN's investment approach recognises the significance of strong processes and a robust governance regime and, accordingly, each drawdown requires a "triple lock" sign off from its legal, credit and portfolio management teams. This is in addition to the extensive portfolio management capabilities SQN inherited within Amberton Asset Management.

Β 

Outlook

Β 

The Company has made good, solid progress on process, governance, credit quality, rationalisation of platform investment and secured direct lending since SQN's appointment. The outlook for direct lending opportunities remains very promising, and the Company already has an abundant pipeline of investment opportunities to consider during the coming months.

Β 

Notes:

1Based on invested and committed capital as at July 2017.

2These target returns are targets only and not profit forecasts. There can be no assurance that the targets can or will be met and they should not be seen as an indication of the Company's expected or actual results or returns. Accordingly, investors should not place any reliance on the target returns in deciding whether to invest in the Company or assume that the Company will make any distributions at all.

Β 

Β 

For further information please contact:

SQN Asset Management Limited

Neil Roberts

Dawn Kendall

tel: +44 1932 575 888

Cantor Fitzgerald Europe

Sue Inglis

tel: +44 20 7894 8016

Buchanan Communications

Charles Ryland/Vicky Hayns/Henry Wilson

tel: +44 20 7466 5000

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
PFULIFVATRIFIID
Date   Source Headline
25th Mar 20227:00 amRNSHalf-year Report
24th Mar 20223:02 pmRNSNet Asset Value(s)
24th Feb 20227:00 amRNSNet Asset Value(s)
25th Jan 20227:00 amRNSNet Asset Value(s)
11th Jan 20223:30 pmRNSHolding(s) in Company
10th Jan 20227:00 amRNSManagement Arrangements
29th Dec 20212:06 pmRNSSecond Price Monitoring Extn
29th Dec 20212:00 pmRNSPrice Monitoring Extension
24th Dec 202112:00 pmRNSNet Asset Value(s)
16th Dec 20213:30 pmRNSB Share Scheme
16th Dec 20213:15 pmRNSResult of AGM and GM
15th Dec 20215:30 pmRNSHolding(s) in Company
29th Nov 20217:00 amRNSNet Asset Value(s)
4th Nov 20211:03 pmRNSHolding(s) in Company
28th Oct 20219:00 amRNSNet Asset Value(s)
21st Oct 20212:00 pmRNSPortfolio Manager Update
21st Oct 20217:05 amRNSPublication of a circular
21st Oct 20217:00 amRNSAnnual Financial Report
5th Oct 202111:28 amRNSReview of Material Loan
25th Aug 20217:00 amRNSMonthly Net Asset Value and Fact Sheet
20th Aug 20217:00 amRNSAmendment and Termination of IMA
11th Aug 20217:00 amRNSMonthly net asset value and fact sheet
12th Jul 20218:37 amRNSMonthly Net Asset Value and Fact Sheet
7th Jul 20217:00 amRNSB Share Scheme
5th Jul 20217:00 amRNSPortfolio Manager Update
25th Jun 20214:55 pmRNSPortfolio Manager Update
24th Jun 202112:04 pmRNSChange of Auditors
8th Jun 20215:02 pmRNSReview of Film Production Financing
1st Jun 20217:00 amRNSReview of Film Production Financing
26th May 20217:00 amRNSMonthly Net Asset Value and Fact Sheet
11th May 20213:00 pmRNSPortfolio Manager Update
4th May 202112:16 pmRNSB Share Scheme
28th Apr 20217:00 amRNSMonthly Net Asset Value and Fact Sheet
31st Mar 20217:00 amRNSCompletion of buyback of management shares
24th Mar 20217:00 amRNSMonthly Net Asset Value and Fact Sheet
24th Mar 20217:00 amRNSHalf-year Report
23rd Mar 20214:05 pmRNSResult of Meeting
19th Mar 202112:30 pmRNSHolding(s) in Company
11th Mar 20217:00 amRNSAdditional information re publication of circular
26th Feb 202111:00 amRNSPublication of a circular
26th Feb 20217:00 amRNSMonthly Net Asset Value and Fact Sheet
28th Jan 20217:00 amRNSMonthly Net Asset Value and Fact Sheet
31st Dec 20208:31 amRNSMonthly Net Asset Value and Fact Sheet
16th Dec 20206:13 pmRNSResult of AGM
26th Nov 20207:00 amRNSMonthly Net Asset Value, Dividend and Fact Sheet
29th Oct 20207:00 amRNSMonthly Net Asset Value and Fact Sheet
9th Oct 20207:00 amRNSAnnual Financial Report
28th Sep 20204:45 pmRNSMonthly Net Asset Value and Fact Sheet
28th Sep 20201:00 pmRNSDisclosure of Rights attaching to Shares
17th Sep 20204:15 pmRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.